NAUT Nautilus Biotechnology: Accounting Value per Share

Graphic logo of Nautilus Bio (NAUT)

The price-to-book ratio per share demonstrates that the metric level is 1.03. Nautilus Biotechnology (NAUT) develops tools for proteome research, targeting the B2B R&D sector. Business success relies on system precision and the adoption of proteomics by the scientific community. An innovative AI-driven IT architecture ensures long-term customer retention and steady growth of the user base.

Nautilus Biotechnology (NAUT) Equity per Share: for the period 07/04/2022 - 10/27/2026

Nautilus Biotechnology, Inc. - analytical breakdowns and key metrics (NAUT)

- price and consensus price forecast:
Stock Quotes Nautilus Biotechnology Inc|NAUT - Analyst Consensus Forecast
- market capitalization data:
Market Valuation Nautilus Bio|NAUT - Aggregate Business Value
- book capitalization data:
Book Value per Share Nautilus Biotechnology|NAUT - Accounting Capitalization|Market Value to Book Value Ratio nautilus.bio|NAUT - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Nautilus Biotechnology|NAUT - Long-Term Debt to Capital|Short-Term Debt to Equity Nautilus Biotechnology Inc|NAUT - Company Aggregate Debt|Debts to Book Capitalization Nautilus Bio
Analysis of all company metrics:nautilus.bio (NAUT)
Manufactured products of Nautilus Biotechnology Inc

Energy cost optimization of Nautilus Biotechnology (NAUT) IT platforms and transparent management are strengthening the issuer's internal capital. By analyzing the book value per share, an investor can see the remaining equity after all liabilities are settled, which allows for an assessment of the real asset value per share and determines the business's fundamental resilience to market shocks.

Competitor analysis

Tempus AI, Inc. - Accounting Value per Share|Qiagen Corp (QGEN) - Book Value per Share|IONS - Accounting Value per Share|repligen.com (RGEN) - Book Price of a Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|sarepta.com - Book Value per Share|Twist Bioscience, Inc. (TWST) - Net Assets per Single Share|TXG - Equity per Share|NTLA: Book Value per Share|Book Value per Share Stoke Corp|BLFS (BioLife Solutions, Inc.) - Accounting Value per Share|Book Value per Share wavelifesciences.com (WVE)|Accounting Value per Share Maze Therapeutics|Book Price of a Share Sionna Therapeutics, Inc. (SION)|Book Value per Share PRME|Taysha Corp - Net Assets per Share|QURE - Net Assets per Single Share|meiragtx.com (MGTX) - Net Assets per Single Share|RGNX: Accounting Value per Share|SLDB (Solid Biosciences Inc) - Book Value per Share|OCGN: Net Assets per Single Share|Net Assets per Share PacBio Corp (PACB)|Benitec Biopharma Inc. (BNTC) - Accounting Value per Share|Accounting Value of a Share designtx.com (DSGN)|Book Value per Share Rocket Pharmaceuticals, Inc. RCKT|Net Assets per Single Share 4DMT FDMT|Book Value per Share LXEO (Lexeo)|KRRO: Net Assets per Share|Net Assets per Single Share EDIT|Net Asset Value per Share silence-therapeutics.com|ProQR (PRQR) - Accounting Value per Share|Book Price of a Share Codexis Bio|Sangamo - Book Value per Share|Net Asset Value per Share Metagenomi Therapeutics (MGX)|Precision BioSciences, Inc. - Book Value per Share|Accounting Value per Share Generation Bio Co GBIO|Book Value per Share Boundless Bio (BOLD)|XCUR: Accounting Value of a Share|Net Assets per Single Share imunon.com|PHIO (Phio Pharmaceuticals Corp.) - Equity per Share|Net Assets per Single Share MBIO (Mustang Bio Inc)|Net Asset Value per Share RNAZ|Net Assets per Single Share Bionano Genomics, Inc. (BNGO)|Net Assets per Single Share APDN (Applied DNA Sciences Inc)|BLUE: Net Assets per Single Share|Net Asset Value per Share ImmunoPrecise Antibodies Ltd IPA|Book Value per Share OMGA|singulargenomics.com (OMIC) - Book Value of One Share|Accounting Value per Share RGLS|SYRS (Syros Pharmaceuticals Inc.) - Net Asset Value per Share|Net Assets per Single Share Codex DNA (TBIO)|Equity per Share TRACON Pharmaceuticals, Inc|Book Value per Share UBX